Identification of NLRP3PYD Homo-Oligomerization Inhibitors with Anti-Inflammatory Activity
暂无分享,去创建一个
R. Gozalbes | F. Karami | S. Hosseinkhani | M. Nikkhah | S. Barigye | E. Serrano-Candelas | M. Orzáez | Paula M. Soriano-Teruel | M. Sancho | S. Moasses Ghafary | Shima Lotfollahzadeh | Iván Fernández-Pérez
[1] Mohsen Isazadeh,et al. Split-luciferase complementary assay of NLRP3 PYD-PYD interaction indicates inflammasome formation during inflammation. , 2021, Analytical biochemistry.
[2] H. Fearnhead,et al. Apoptosome Formation through Disruption of the K192-D616 Salt Bridge in the Apaf-1 Closed Form , 2021, ACS omega.
[3] Kunal Kumar,et al. Discovery and characterization of small-molecule inhibitors of NLRP3 and NLRC4 inflammasomes , 2021, The Journal of biological chemistry.
[4] M. Korte,et al. The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer’s disease , 2020, Proceedings of the National Academy of Sciences.
[5] J. Mudgal,et al. Inhibition of NLRP3-inflammasome mediated IL-1β release by phenylpropanoic acid derivatives: in-silico and in-vitro approach. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[6] H. Fearnhead,et al. Loss of WD2 subdomain of Apaf-1 forms an apoptosome structure which blocks activation of caspase-3 and caspase-9. , 2020, Biochimie.
[7] J. MacDonald,et al. ATP-Binding and Hydrolysis in Inflammasome Activation , 2020, Molecules.
[8] R. Goldbach-Mansky,et al. Human Autoinflammatory Diseases Mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-Inflammasome Dysregulation Updates on Diagnosis, Treatment, and the Respective Roles of IL-1 and IL-18 , 2020, Frontiers in Immunology.
[9] V. Hodnik,et al. Selective inhibition of NLRP3 inflammasome by designed peptide originating from ASC , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] E. Elinav,et al. Inflammasome activation and regulation: toward a better understanding of complex mechanisms , 2020, Cell Discovery.
[11] S. Cuzzocrea,et al. Focus on the Role of NLRP3 Inflammasome in Diseases , 2020, International journal of molecular sciences.
[12] Elaheh Sadat Hosseini,et al. The Lumiptosome, an engineered luminescent form of the apoptosome can report cell death by using the same Apaf-1 dependent pathway , 2020, Journal of Cell Science.
[13] Joo Young Lee,et al. Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3‐Driven Inflammation and Gouty Arthritis , 2020, Arthritis & rheumatology.
[14] Yang Wang,et al. MCC950, a Selective Inhibitor of NLRP3 Inflammasome, Reduces the Inflammatory Response and Improves Neurological Outcomes in Mice Model of Spinal Cord Injury , 2020, Frontiers in Molecular Biosciences.
[15] Maryam Nikkhah,et al. Optimization of Experimental Variables Influencing Apoptosome Biosensor in HEK293T Cells , 2020, Sensors.
[16] Ajay Kumar,et al. Discovery of benzo[cd]indol-2-one and benzylidene-thiazolidine-2,4-dione as new classes of NLRP3 inflammasome inhibitors via ER-β structure based virtual screening. , 2019, Bioorganic chemistry.
[17] D. Philpott,et al. Canonical and noncanonical inflammasomes in intestinal epithelial cells , 2019, Cellular microbiology.
[18] T. Jin,et al. Pharmacological Inhibitors of the NLRP3 Inflammasome , 2019, Front. Immunol..
[19] J. Konvalinka,et al. MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition , 2019, PLoS biology.
[20] A. Kwan,et al. Tryptophan Fluorescence Quenching Assays for Measuring Protein-ligand Binding Affinities: Principles and a Practical Guide. , 2019, Bio-protocol.
[21] R. Gozalbes,et al. A new split‐luciferase complementation assay identifies pentachlorophenol as an inhibitor of apoptosome formation , 2019, FEBS open bio.
[22] C. Day,et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition , 2019, Nature Chemical Biology.
[23] J. Ting,et al. The NLRP3 inflammasome: molecular activation and regulation to therapeutics , 2019, Nature Reviews Immunology.
[24] Horacio Pérez-Sánchez,et al. MCC950 closes the active conformation of NLRP3 to an inactive state , 2019, Nature Chemical Biology.
[25] Shijun Zhang,et al. A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury , 2019, Journal of neuroinflammation.
[26] D. Lane,et al. Inhibition of NLRP3 inflammasome activation by cell-permeable stapled peptides , 2019, Scientific Reports.
[27] Houhui Song,et al. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors , 2019, Cell Death & Disease.
[28] Qingsong Liu,et al. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity , 2018, Nature Communications.
[29] G. Turcatti,et al. Assay for high-throughput screening of inhibitors of the ASC-PYD inflammasome core filament , 2018, Cell stress.
[30] Elaheh Sadat Hosseini,et al. Apoptosome formation upon overexpression of native and truncated Apaf-1 in cell-free and cell-based systems , 2018, Archives of biochemistry and biophysics.
[31] Xianming Deng,et al. Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases , 2018, EMBO molecular medicine.
[32] Qingsong Liu,et al. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders , 2017, The Journal of experimental medicine.
[33] S. De,et al. POP1 might be recruiting its type‐Ia interface for NLRP3‐mediated PYD‐PYD interaction: Insights from MD simulation , 2017, Journal of molecular recognition : JMR.
[34] N. Kopitar-Jerala. The Role of Interferons in Inflammation and Inflammasome Activation , 2017, Front. Immunol..
[35] F. Meissner,et al. NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain , 2017, The Journal of experimental medicine.
[36] S. Yao,et al. NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies , 2017, Front. Cell. Neurosci..
[37] G. Rivas,et al. ASC Pyrin Domain Self-associates and Binds NLRP3 Protein Using Equivalent Binding Interfaces * , 2016, The Journal of Biological Chemistry.
[38] V. Dixit,et al. Inflammasomes: mechanism of assembly, regulation and signalling , 2016, Nature Reviews Immunology.
[39] E. Elinav,et al. Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis , 2015, Cell.
[40] C. Sasakawa,et al. Molecular mechanisms regulating NLRP3 inflammasome activation , 2015, Cellular and Molecular Immunology.
[41] Anindita Das,et al. Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse , 2015, Journal of cardiovascular pharmacology.
[42] Bertrand Friguet,et al. NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases , 2015, Redox biology.
[43] S. Hosseinkhani,et al. Split-luciferase complementary assay: applications, recent developments, and future perspectives , 2014, Analytical and Bioanalytical Chemistry.
[44] F. Sutterwala,et al. Mechanism of NLRP3 inflammasome activation , 2014, Annals of the New York Academy of Sciences.
[45] G. Núñez,et al. 3,4-Methylenedioxy-β-nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the Inflammasome* , 2013, The Journal of Biological Chemistry.
[46] O. Beretta,et al. The NLRP3 inflammasome affects DNA damage responses after oxidative and genotoxic stress in dendritic cells , 2013, European journal of immunology.
[47] E. Latz,et al. Activation and regulation of the inflammasomes , 2013, Nature Reviews Immunology.
[48] Christoph H. Emmerich,et al. The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system , 2013, The Biochemical journal.
[49] S. Hosseinkhani,et al. Design and development of a whole-cell luminescent biosensor for detection of early-stage of apoptosis. , 2012, Biosensors & bioelectronics.
[50] K. Tracey,et al. Novel role of PKR in inflammasome activation and HMGB1 release , 2012, Nature.
[51] J. Wells,et al. A small molecule inhibitor of Caspase 1 , 2011 .
[52] Pedro Romero,et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. , 2011, Immunity.
[53] R. Flavell,et al. Molecular Mechanism of NLRP3 Inflammasome Activation , 2010, Journal of Clinical Immunology.
[54] E. Alnemri,et al. Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome* , 2010, The Journal of Biological Chemistry.
[55] Kate Schroder,et al. The NLRP3 Inflammasome: A Sensor for Metabolic Danger? , 2010, Science.
[56] J. Ting,et al. Inflammasome-Associated Nucleotide-Binding Domain, Leucine-Rich Repeat Proteins and Inflammatory Diseases1 , 2009, The Journal of Immunology.
[57] V. Dixit,et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome , 2009, The Journal of cell biology.
[58] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[59] B. Cookson,et al. Pyroptosis: host cell death and inflammation , 2009, Nature Reviews Microbiology.
[60] Jingfeng Li,et al. Parthenolide Inhibits IκB Kinase, NF-κB Activation, and Inflammatory Response in Cystic Fibrosis Cells and Mice , 2007 .
[61] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[62] F. Martinon,et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.
[63] S. Srinivasula,et al. The PYRIN-CARD Protein ASC Is an Activating Adaptor for Caspase-1* , 2002, The Journal of Biological Chemistry.
[64] J. Bertin,et al. The PYRIN domain: a novel motif found in apoptosis and inflammation proteins , 2000, Cell Death and Differentiation.
[65] M F Sanner,et al. Python: a programming language for software integration and development. , 1999, Journal of molecular graphics & modelling.
[66] E. Latz,et al. The Inflammasome: Methods and Protocols , 2022, Methods in Molecular Biology.
[67] P. A. Crawford,et al. The ketone metabolite β-hydroxybutyrate blocks NLRP 3 inflammasome – mediated inflammatory disease , 2015 .
[68] R. Terkeltaub,et al. Tophus Biology and Pathogenesis of Monosodium Urate Crystal–Induced Inflammation , 2012 .
[69] Brian K. Shoichet,et al. ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..
[70] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[71] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[72] M. Heinrich,et al. Ethnopharmacology of Mexican asteraceae (Compositae). , 1998, Annual review of pharmacology and toxicology.